Therapy Areas: Inflammatory Diseases
19 September 2017 - The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the Marketing Authorisation Application f...
18 September 2017 - Biotechnology company Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and healthcare company Sanofi on Friday jointly announced encouraging results from the Phase 3 CAFÉ study o...
15 September 2017 - Biotherapeutics comany CSL Behring disclosed on Thursday the receipt of US Food and Drug Administration's (FDA) approval for Privigen [Immune Globulin Intravenous (Human), 10%...
14 September 2017 - - Minneapolis, Minnesota-based R and D Systems, a Bio-Techne Corp. (NASDAQ: TECH) brand, has released its new XL Cytokine Discovery Luminex High Performance Panel, the co...
14 September 2017 - - Minneapolis, Minnesota-based R and D Systems, a Bio-Techne Corp. (NASDAQ: TECH) brand, has released its new XL Cytokine Discovery Luminex High Performance Panel, the co...
14 September 2017 - - San Bruno, California-based neurodegenerative disease therapies developer Neuraltus Pharmaceuticals, Inc. and the John A. Burns School of Medicine, University of Hawaii...